-+ 0.00%
-+ 0.00%
-+ 0.00%

Aldeyra Therapeutics Receives FDA Fast Track Designation for ADX-2191 in Treating Retinitis Pigmentosa

Reuters·08/19/2025 11:01:38

Please log in to view news